George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
Spent several years invested in Hemo, anticipating good news, waiting for RNS'S to land, hoping for partnership deals, buying the dips, averaging down, dreaming of riches, hoping for cures and on it goes. Can't really remember when I first bought in 7 - 8 years ago probably. I do remember it was around 3p. All I got was considerably poorer and a regular kickin'. Hope my luck changes soon.!!!
GLA
Mrindia IMO MOTIF Bio is dead in the water, unless Iclaprim, a cracking product imo, can resurrect some interest,
but the board seem clueless and unable to take it forward, I personally have written it off. I just hope the same
scenario is'nt playing out here, a lot of good people have hung there hats on this including me, but it is looking
similar. I am a lth having bought in at low 2's and added on the way up so am comfortable but getting edgy1